In particular, the presence of tumor-infiltrating CD8+ T cells in primary high-grade serous ovarian tumors is strongly associated with prolonged overall survival (OS) and disease-specific survival (DSS) [6,7,8,9,10,11]. This evidence concerns the gene CD8A and neoplasm.